SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying following a strong earnings report that beat analyst estimates for both revenue and earnings per share, signaling a potential turning point for the stock. The community is actively debating whether this movement represents a sustainable recovery for the solar sector or if it is merely a temporary bounce driven by short covering and speculative trading.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors weigh strong Q3 revenue beats and international growth against continued concerns over management's diversification strategy and potential dilution. The community remains deeply divided, with bulls pointing to the company's evolving global medical cannabis footprint as a long-term catalyst, while vocal skeptics remain focused on historical share price declines and skepticism toward the CEO's leadership.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

XPL is experiencing high volatility as investors debate whether the recent price swings and exchange listings represent a genuine utility-driven recovery or a pump-and-dump scheme. The community remains deeply divided, with some highlighting the project's stablecoin infrastructure and potential for adoption, while others express frustration over significant price declines and lack of transparency.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant selling pressure and heightened volatility as investors weigh disappointing delivery figures against the company's aggressive pivot toward AI, robotics, and the potential SpaceX IPO. The community remains deeply divided, with bears pointing to stagnating core automotive demand and leadership concerns, while bulls continue to focus on the long-term potential of the autonomous technology and energy storage sectors.

Investment Managers Series Trust II - Tradr 2X Long AAOI Daily ETF

The Tradr 2X Long AAOI Daily ETF

Investors are actively trading AAOX, a newly launched 2X leveraged ETF designed to amplify the daily performance of Applied Optoelectronics within the high-growth optical networking and AI sector. The community is focused on technical setups and the potential for increased volatility, while navigating the accessibility of this new leveraged instrument across various brokerage platforms.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for investors due to its advanced post-quantum cryptographic security features, which are gaining recognition following recent industry research. While the community remains divided between long-term bulls betting on its technological utility and bears skeptical of its price trajectory, sentiment is shifting as discussions highlight its potential role in secure blockchain infrastructure.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending as investors react to the FDA's acceptance of its BLA resubmission for RP1 in advanced melanoma, setting a PDUFA date of April 10, 2026. The community remains deeply divided, with some traders betting on a turnaround and potential short squeeze, while skeptics warn of persistent regulatory hurdles and the risk of further delays similar to the previous rejection.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing significant upward momentum and high trading volume driven by multiple large orders for its 800G data center transceivers from a major hyperscale customer. The stock is currently a primary focus for traders, with community discussions heavily centered on potential short squeezes, its role in the AI infrastructure supercycle, and the aggressive positioning of institutional players like Jane Street.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense speculative activity as investors speculate on potential buyout interest from tech giants like Amazon, Apple, and SpaceX, fueled by reports of emerging strategic partnerships and the broader space sector's push toward direct-to-device connectivity. The community remains deeply divided between those betting on an imminent acquisition at a significant premium and those cautioning that these valuation expectations rely on unverified rumors.

Fidelity Covington Trust - Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF is currently gaining attention from investors evaluating top-tier communication sector holdings for long-term growth. Discussions center on the fund's heavy exposure to major tech and media companies, with active debate among the community regarding the potential influence of artificial intelligence on the broader industry and its impact on performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, nine have...

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Key PointsThe chair of Stoke Therapeutics disclosed selling 4,355 shares for roughly $174,000 at around $40.00 per share on March 10, 2026...

Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading Volume  - Still a Buy?

Stoke Therapeutics (NASDAQ:STOK) Sees Strong Trading Volume - Here's What Happened...

Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK

Assenagon Asset Management S.A. boosted its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 36.4% in the fourth quarter, according to its most recent disclosure with the...

Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally

Key PointsThe chief medical officer of Stoke Therapeutics disposed of 14,311 Common Stock shares for a transaction value of $457,000 across three days ending March 19, 2026...

FY2030 Earnings Estimate for STOK Issued By HC Wainwright

Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) - Equities researchers at HC Wainwright issued their FY2030 EPS estimates for Stoke Therapeutics in a research note issued on Friday, March 20th. HC Wainwright analyst A. Ghosh anticipates that the company will earn $4.03 per share for the year. H...

Stoke Therapeutics (NASDAQ:STOK) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered Stoke Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Canaccord Genuity Group Forecasts Strong Price Appreciation for Stoke Therapeutics (NASDAQ:STOK) Stock

Canaccord Genuity Group boosted their target price on Stoke Therapeutics from $36.00 to $60.00 and gave the stock a "buy" rating in a research report on Friday...

Stoke Therapeutics (NASDAQ:STOK) Insider Barry Ticho Sells 1,461 Shares

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) insider Barry Ticho sold 1,461 shares of the stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average...

Stoke Therapeutics (NASDAQ:STOK) Insider Sells $60,517.54 in Stock

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) insider Jason Hoitt sold 1,931 shares of the business's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $31.34, for a total value of $60,517.54. Following the sale, the insider owned 10,276 shares of...

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Stoke Therapeutics Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$32.74
Prev Close	$31.99
Open	$31.04
Dividend Yield	0.00%
50-Day Moving Average	$33.09
Beta	1.31
Avg. Volume	986,806.54
PE Ratio	-215.42

52-Week High	$40.22
52-Week Low	$5.35
Market Capitalization	$1.89B
EPS (Annual)	-$0.1163
Price to Book	5.35
Revenue Per Employee	$1.08M

STOK
Stoke Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STOK News

STOKStoke Therapeutics Inc